Patent Assignment
Reel/Frame 025737/0990
Release of Security Interest
Recorded: 2011-02-03
Pages: 8
Assignor
CREDIT SUISSE AG
Executed: 2011-01-31
Assignee
KING PHARMACEUTICALS, INC.
501 FIFTH STREET, BRISTOL, TENNESSEE, 37620
Covered Properties
(29)
1-Carba(Dethia)-3-Hydroxy-3-Cephem Ester Crystalline and Crystalline Solvate Thereof
Patent:
4,782,144 →
Application:
07/095,721 →
Photochemical Conversion of Cephalosporins, 1-Carba(1-Dethia) Cephalosporins and 1-Oxa(1-Dethia)Cephalosporins
Patent:
4,888,100 →
Application:
07/324,169 →
Process and Intermediates for Chiral Epoxides
Patent:
5,097,049 →
Application:
07/518,384 →
Dmf Solvates of a Beta-Lactam Antibiotic
Patent:
4,977,257 →
Application:
07/530,140 →
Beta-Lactam Antibiotics
Patent:
5,142,039 →
Application:
07/588,381 →
Enantiomerically Selective Biocatalyzed Acylation
Patent:
5,057,607 →
Application:
07/591,586 →
Monohydrate and Dmf Solvates of a New Carbacephem Antibiotic
Patent:
5,091,525 →
Application:
07/601,021 →
Ring-Closure Method for 1-Carbacephalosporin Six-Membered Ring
Patent:
5,089,610 →
Application:
07/691,257 →
Process of Enantiomeric Separation of Carbacephem Intermediates
Patent:
5,142,038 →
Application:
07/734,394 →
Intermediates to 1-Carbacephalosporins and Process for Preparation Thereof
Patent:
5,159,073 →
Application:
07/735,747 →
Novel 4-(2,3 Epoxy Propane) Azetidinones
Patent:
5,116,972 →
Application:
07/744,857 →
New Amino Protecting Group
Patent:
5,169,945 →
Application:
07/750,214 →
Process and Intermediates for Chiral Epoxides
Patent:
5,183,910 →
Application:
07/770,676 →
Bicyclic Beta-Lactam Antibiotics
Patent:
5,239,068 →
Application:
07/871,376 →
Process and Intermediates for Chiral Epoxides
Patent:
5,256,807 →
Application:
07/881,913 →
Intermediates to 1-Carbacephalosporins and Process for Preparation Thereof
Patent:
5,225,553 →
Application:
07/889,221 →
New Amino Protecting Group
Patent:
5,239,069 →
Application:
07/918,196 →
Process and Intermediates for Chiral Epoxides
Patent:
5,296,615 →
Application:
08/012,109 →
Amino Protecting Group
Patent:
5,283,329 →
Application:
08/025,301 →
Process for Converting Loracarbef Dihydrate to Loracarbef Monohydrate
Patent:
5,374,719 →
Application:
08/071,550 →
Process for Preparing Crystalline Beta-Lactam Monohydrate
Patent:
5,352,782 →
Application:
08/071,552 →
Loracarbef Isopropanolate and a Process for Converting Loracarbef Isopropanolate to Loracarbef Monohydrate
Patent:
5,399,686 →
Application:
08/072,204 →
Loracarbef Hydrochloride C1-C3 Alcohol Solvates and Uses Thereof
Patent:
5,550,231 →
Application:
08/077,305 →
Azetidinone Intermediates to Carbacephalosporins and Process
Patent:
5,453,503 →
Application:
08/104,383 →
Loracarbef Isopropanolate
Patent:
5,672,700 →
Application:
08/347,759 →
Process for Preparing Loracarbef Monohydrate
Patent:
5,580,977 →
Application:
08/396,948 →
Azetidinone Intermediates to Carbacephalosporins and Process
Patent:
5,646,275 →
Application:
08/428,613 →
Loracarbef Hydrochloride C1-C3 Alcohol Solvates and Uses Thereof
Patent:
5,578,720 →
Application:
08/444,124 →
Azetidinone Intermediates to Carbacephalosporins and Process
Patent:
5,637,692 →
Application:
08/464,480 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 19, 2001
From: KING PHARMACEUTICALS, INC.
To: CREDIT SUISSE FIRST BOSTON
Reel/Frame 012350/0860 →
Security Agreement
Dec 30, 2008
From: KING PHARMACEUTICALS, INC.
To: CREDIT SUISSE, AS AGENT
Reel/Frame 022034/0883 →
Release of Security Interest
May 11, 2010
From: KING PHARMACEUTICALS, INC.
To: CREDIT SUISSE AG
Reel/Frame 024369/0074 →
Security Agreement
May 14, 2010
From: KING PHARMACEUTICALS, INC.
To: CREDIT SUISSE AG
Reel/Frame 024380/0645 →
Release of Security Interest
Feb 2, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS, INC.
Reel/Frame 025735/0513 →
Release of Security Interest
Feb 4, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS, INC.
Reel/Frame 025746/0793 →